Searching for "start-up" found 4

Switzerland: A Sea Change in the Biotech Start-up Ecosystem?

Switzerland Switzerland: A Sea Change in the Biotech Start-up Ecosystem?

Switzerland In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC) firm aiming to support founders and start-ups in Europe, highlighted how the European VC & the Switzerland Biotech Investment space has evolved over the past decade and the funding challenges that remain. He also…

5 US Rare Disease Start-Ups to Watch

USA 5 US Rare Disease Start-Ups to Watch

USA Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan therapies in Europe, here we move to the world’s biggest biopharmaceutical market and R&D hub, shining the spotlight on five of the most important and innovative rare-disease start-ups in the USA. The US…

5 European Rare Disease Start-Ups to Watch

Europe 5 European Rare Disease Start-Ups to Watch

Europe With Rare Disease Day falling on 28 February, PharmaBoardroom dedicates this month to exploring the global rare disease landscape, highlighting key trends and developments as well as profiling the most innovative global players in this space. We start the party off with five of the most promising clinical-stage biotech companies…

Global Pharma has Reinvented R&D: Will Canadian Start-Ups Lead the Next Phase?

Canada Global Pharma has Reinvented R&D: Will Canadian Start-Ups Lead the Next Phase?

Canada John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the forefront of the next wave of global biopharmaceutical R&D. BlueRock Therapeutics, a promising North American start-up with a new Parkinson’s disease drug, was recently sold to Germany’s Bayer at a $1 billion valuation.…